TD Cowen raised the firm’s price target on Cigna (CI) to $338 from $333 and keeps a Buy rating on the shares. The firm updates its estimates following Q4 results and formal 2026 guidance. they also believe 4Q represented a meaningful catalyst for shares, as it removes two key overhangs over the past two years: stop loss and PBM reform.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CI:
- Cigna: Regulatory Overhang Eases, Evernorth Growth Drives Renewed Buy Rating and Earnings Upside
- Cigna: Regulatory Overhangs Easing and PBM Model Transition Drive Clearer Profitability Outlook and Attractive Risk-Reward Supporting Buy Rating
- Cigna price target lowered to $303 from $305 at Barclays
- Cigna Earnings Call: Growth Holds Amid PBM Overhaul
- Cigna increases quarterly dividend to $1.56 per share